FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Prothena's Trailing 12-Month Free Cash Flow is $-162.36 Mil, and Market Cap is $1,182.98 Mil. Therefore, Prothena's FCF Yield % for today is -11.57%.
The historical rank and industry rank for Prothena's FCF Yield % or its related term are showing as below:
PRTA'
s FCF Yield % Range Over the Past 10 Years
Min: -31.32 Med: -5.41 Max: 7.92
Current: -11.57
During the past 13 years, the highest FCF Yield % of Prothena was 7.92%. The lowest was -31.32%. And the median was -5.41%.
PRTA's FCF Yield % is ranked better than 55.63% of 1555
companies
in the Biotechnology industry
Industry Median: -14.18
vs PRTA: -11.57
Prothena's FCF Margin % for the quarter that ended in Mar. 2024 was -146,308.00%.
Prothena FCF Yield % Historical Data
The historical data trend for Prothena's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Prothena's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prothena's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prothena's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Prothena's FCF Yield % falls into.
Prothena FCF Yield % Calculation
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Prothena's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prothena FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Prothena FCF Yield % Related Terms
Thank you for viewing the detailed overview of Prothena's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRTA has been successfully added to your 